                         SEQUENCE LISTING

<110>  UNIVERSITE DE BORDEAUX et al
 
<120>  METHODE POUR TRAITER UNE INFECTION PAR LE VIRUS DE 
       L'IMMUNODEFICIENCE HUMAINE

<130>  B2858PC

<160>  17    

<170>  PatentIn version 3.5

<210>  1
<211>  9
<212>  PRT
<213>  artificial

<220>
<223>  peptide

<400>  1

Val Leu Ala Glu Ala Met Ser Gln Val 
1               5                   


<210>  2
<211>  8
<212>  PRT
<213>  artificial

<220>
<223>  peptide

<400>  2

Phe Leu Gly Lys Ile Trp Pro Ser 
1               5               


<210>  3
<211>  9
<212>  PRT
<213>  artificial

<220>
<223>  pepetide

<400>  3

Tyr Gln Tyr Met Asp Asp Leu Tyr Val 
1               5                   


<210>  4
<211>  8
<212>  PRT
<213>  artificial

<220>
<223>  peptide

<400>  4

Phe Leu Trp Met Gly Tyr Glu Leu 
1               5               


<210>  5
<211>  10
<212>  PRT
<213>  artificial

<220>
<223>  peptide

<400>  5

Tyr Glu Leu His Pro Asp Lys Trp Thr Val 
1               5                   10  


<210>  6
<211>  10
<212>  PRT
<213>  artificial

<220>
<223>  peptide

<400>  6

Lys Leu Val Asp Phe Arg Glu Leu Asn Lys 
1               5                   10  


<210>  7
<211>  9
<212>  PRT
<213>  artificial

<220>
<223>  peptide

<400>  7

Ala Ile Phe Gln Ser Ser Met Thr Lys 
1               5                   


<210>  8
<211>  10
<212>  PRT
<213>  artificial

<220>
<223>  peptide

<400>  8

Arg Tyr Pro Leu Thr Phe Gly Trp Cys Tyr 
1               5                   10  


<210>  9
<211>  10
<212>  PRT
<213>  artificial

<220>
<223>  peptide

<400>  9

Thr Val Gln Pro Ile Val Leu Pro Glu Lys 
1               5                   10  


<210>  10
<211>  9
<212>  PRT
<213>  artificial

<220>
<223>  peptide

<400>  10

Asp Val Gly Asp Ala Tyr Phe Ser Val 
1               5                   


<210>  11
<211>  9
<212>  PRT
<213>  artificial

<220>
<223>  peptide

<400>  11

Ser Pro Arg Thr Leu Asn Ala Trp Val 
1               5                   


<210>  12
<211>  9
<212>  PRT
<213>  artificial

<220>
<223>  peptide

<400>  12

Ser Pro Ala Ile Phe Gln Ser Ser Met 
1               5                   


<210>  13
<211>  9
<212>  PRT
<213>  artificial

<220>
<223>  peptide

<400>  13

Gly Pro Lys Val Lys Gln Trp Pro Leu 
1               5                   


<210>  14
<211>  9
<212>  PRT
<213>  artificial

<220>
<223>  peptide

<400>  14

Glu Glu Met Asn Leu Pro Gly Arg Trp 
1               5                   


<210>  15
<211>  9
<212>  PRT
<213>  artificial

<220>
<223>  peptide

<400>  15

Ser Met Thr Lys Ile Leu Glu Pro Phe 
1               5                   


<210>  16
<211>  9
<212>  PRT
<213>  artificial

<220>
<223>  peptide

<400>  16

Thr Val Leu Asp Val Gly Asp Ala Tyr 
1               5                   


<210>  17
<211>  14
<212>  PRT
<213>  artificial

<220>
<223>  peptide

<400>  17

Gln Tyr Ile Lys Ala Asn Ser Lys Phe Ile Gly Ile Thr Glu 
1               5                   10                  


